| 发明名称 |
USE OF TYROSINE KINASE INHIBITOR IN CANCER TREATMENT |
| 摘要 |
The present invention provides methods for reducing apoptosis of non-cancerous cells during a cancer treatment and beneficial effects associated with reducing such apoptosis. In particular, methods of the invention comprise administering a tyrosine kinase inhibitor to a cancer patient who is undergoing cancer treatment in order to reduce apoptosis of non-cancerous cells. |
| 申请公布号 |
US2016228436(A1) |
申请公布日期 |
2016.08.11 |
| 申请号 |
US201415029617 |
申请日期 |
2014.10.17 |
| 申请人 |
THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE |
发明人 |
Reyland Mary E.;Wie Sten;DeGregori James |
| 分类号 |
A61K31/506;A61K31/5025;A61K31/496;A61K31/517 |
主分类号 |
A61K31/506 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for reducing apoptosis of non-cancerous cells during a cancer treatment, said method comprising administering a therapeutically effective amount of a tyrosine kinase inhibitor prior to administering a cancer treatment to a cancer patient. |
| 地址 |
Denver CO US |
